Skip to main content
logo
Pulmonx Corporation (LUNG)
NASDAQ: LUNG · Real-Time Price · USD
2.250
+0.040 (1.81%)
Jan 2, 2026, 11:14 AM EST - Market open

Revenue by Product

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
Interventional Pulmonology
83.79M
Log In
Log In
Log In
Log In
Upgrade
Interventional Pulmonology Growth
22.01%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202016 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2016 - 2019
United States
56.47M
Log In
Log In
Log In
Log In
Upgrade
United States Growth
22.97%
Log In
Log In
Log In
Log In
Upgrade
Europe, Middle-East and Africa
22.33M
Log In
Log In
Log In
Log In
Upgrade
Europe, Middle-East and Africa Growth
61.31%
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific
4.44M
Log In
Log In
Log In
Log In
Upgrade
Asia Pacific Growth
46.84%
Log In
Log In
Log In
Log In
Upgrade
Other International
556.00K
Log In
Log In
Log In
Log In
Upgrade
Other International Growth
39.35%
Log In
Log In
Log In
Log In
Upgrade
Germany
-
Log In
Log In
Log In
Log In
Upgrade
Germany Growth
-
Log In
Log In
Log In
Log In
Upgrade
France
-
Log In
Log In
Log In
Log In
Upgrade